vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and USA TODAY Co., Inc. (TDAY). Click either name above to swap in a different company.

USA TODAY Co., Inc. is the larger business by last-quarter revenue ($548.5M vs $268.1M, roughly 2.0× ACADIA PHARMACEUTICALS INC). USA TODAY Co., Inc. runs the higher net margin — 3.6% vs 1.4%, a 2.3% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -4.0%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -7.4%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

USA Today Co., Inc., formerly known as Gannett, is an American mass media holding company headquartered in New York City. It is the largest U.S. newspaper publisher as measured by total daily circulation.

ACAD vs TDAY — Head-to-Head

Bigger by revenue
TDAY
TDAY
2.0× larger
TDAY
$548.5M
$268.1M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+13.8% gap
ACAD
9.7%
-4.0%
TDAY
Higher net margin
TDAY
TDAY
2.3% more per $
TDAY
3.6%
1.4%
ACAD
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
5.3%
-7.4%
TDAY

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ACAD
ACAD
TDAY
TDAY
Revenue
$268.1M
$548.5M
Net Profit
$3.6M
$19.9M
Gross Margin
Operating Margin
-1.7%
Net Margin
1.4%
3.6%
Revenue YoY
9.7%
-4.0%
Net Profit YoY
EPS (diluted)
$0.02
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
TDAY
TDAY
Q1 26
$268.1M
$548.5M
Q4 25
$284.0M
$585.0M
Q3 25
$278.6M
$560.8M
Q2 25
$264.6M
$584.9M
Q1 25
$244.3M
$571.6M
Q4 24
$259.6M
$621.3M
Q3 24
$250.4M
$612.4M
Q2 24
$242.0M
$639.8M
Net Profit
ACAD
ACAD
TDAY
TDAY
Q1 26
$3.6M
$19.9M
Q4 25
$273.6M
$-30.1M
Q3 25
$71.8M
$-39.2M
Q2 25
$26.7M
$78.4M
Q1 25
$19.0M
$-7.3M
Q4 24
$143.7M
$64.3M
Q3 24
$32.8M
$-19.7M
Q2 24
$33.4M
$13.7M
Gross Margin
ACAD
ACAD
TDAY
TDAY
Q1 26
Q4 25
90.8%
41.5%
Q3 25
92.2%
37.2%
Q2 25
92.2%
38.5%
Q1 25
91.7%
37.6%
Q4 24
91.6%
39.5%
Q3 24
92.5%
38.6%
Q2 24
92.5%
38.8%
Operating Margin
ACAD
ACAD
TDAY
TDAY
Q1 26
-1.7%
Q4 25
6.1%
7.4%
Q3 25
12.8%
-3.9%
Q2 25
12.2%
-1.6%
Q1 25
7.9%
1.7%
Q4 24
59.1%
1.0%
Q3 24
12.6%
-1.0%
Q2 24
12.6%
1.1%
Net Margin
ACAD
ACAD
TDAY
TDAY
Q1 26
1.4%
3.6%
Q4 25
96.3%
-5.1%
Q3 25
25.8%
-7.0%
Q2 25
10.1%
13.4%
Q1 25
7.8%
-1.3%
Q4 24
55.4%
10.4%
Q3 24
13.1%
-3.2%
Q2 24
13.8%
2.1%
EPS (diluted)
ACAD
ACAD
TDAY
TDAY
Q1 26
$0.02
$0.12
Q4 25
$1.61
$-0.09
Q3 25
$0.42
$-0.27
Q2 25
$0.16
$0.42
Q1 25
$0.11
$-0.05
Q4 24
$0.86
$0.47
Q3 24
$0.20
$-0.14
Q2 24
$0.20
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
TDAY
TDAY
Cash + ST InvestmentsLiquidity on hand
$85.2M
Total DebtLower is stronger
$726.8M
Stockholders' EquityBook value
$141.4M
Total Assets
$1.6B
$1.8B
Debt / EquityLower = less leverage
5.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
TDAY
TDAY
Q1 26
$85.2M
Q4 25
$177.7M
$90.2M
Q3 25
$258.0M
$75.2M
Q2 25
$253.6M
$88.5M
Q1 25
$217.7M
$85.9M
Q4 24
$319.6M
$106.3M
Q3 24
$155.1M
$101.8M
Q2 24
$177.1M
$98.9M
Total Debt
ACAD
ACAD
TDAY
TDAY
Q1 26
$726.8M
Q4 25
$954.2M
Q3 25
$971.8M
Q2 25
$988.9M
Q1 25
$1.0B
Q4 24
$1.1B
Q3 24
$992.1M
Q2 24
$1.0B
Stockholders' Equity
ACAD
ACAD
TDAY
TDAY
Q1 26
$141.4M
Q4 25
$1.2B
$155.1M
Q3 25
$917.3M
$194.0M
Q2 25
$822.4M
$237.1M
Q1 25
$765.2M
$150.1M
Q4 24
$732.8M
$153.1M
Q3 24
$577.2M
$240.5M
Q2 24
$516.7M
$249.8M
Total Assets
ACAD
ACAD
TDAY
TDAY
Q1 26
$1.6B
$1.8B
Q4 25
$1.6B
$1.8B
Q3 25
$1.3B
$1.9B
Q2 25
$1.2B
$2.0B
Q1 25
$1.1B
$2.0B
Q4 24
$1.2B
$2.0B
Q3 24
$976.9M
$2.1B
Q2 24
$914.1M
$2.1B
Debt / Equity
ACAD
ACAD
TDAY
TDAY
Q1 26
5.14×
Q4 25
6.15×
Q3 25
5.01×
Q2 25
4.17×
Q1 25
6.71×
Q4 24
7.05×
Q3 24
4.13×
Q2 24
4.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
TDAY
TDAY
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$6.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
TDAY
TDAY
Q1 26
Q4 25
$-48.7M
$43.4M
Q3 25
$74.3M
Q2 25
$64.0M
Q1 25
$20.3M
$23.3M
Q4 24
$40.4M
$9.0M
Q3 24
$63.2M
Q2 24
$25.0M
Free Cash Flow
ACAD
ACAD
TDAY
TDAY
Q1 26
$6.4M
Q4 25
$30.8M
Q3 25
$73.9M
Q2 25
Q1 25
$9.8M
Q4 24
$-3.8M
Q3 24
$63.2M
Q2 24
FCF Margin
ACAD
ACAD
TDAY
TDAY
Q1 26
1.2%
Q4 25
5.3%
Q3 25
26.5%
Q2 25
Q1 25
1.7%
Q4 24
-0.6%
Q3 24
25.2%
Q2 24
Capex Intensity
ACAD
ACAD
TDAY
TDAY
Q1 26
2.4%
Q4 25
2.2%
Q3 25
0.1%
Q2 25
Q1 25
2.4%
Q4 24
2.1%
Q3 24
0.0%
Q2 24
Cash Conversion
ACAD
ACAD
TDAY
TDAY
Q1 26
Q4 25
-0.18×
Q3 25
1.03×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
0.14×
Q3 24
1.93×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Segment breakdown not available.

TDAY
TDAY

Print and commercial$286.6M52%
Digital$261.9M48%

Related Comparisons